PE/Cyanine7 Anti-Human CD274/PD-L1 Antibody[29E.2A3]

PE/Cyanine7 Anti-Human CD274/PD-L1 Antibody[29E.2A3]

Introducing the PE/Cyanine7 Anti-Human CD274/PD-L1 Antibody [29E.2A3], a cutting-edge product designed to revolutionize the field of immunology. This antibody, meticulously developed by our team of experts, showcases exceptional specificity and sensitivity in detecting CD274/PD-L1, a crucial immune checkpoint protein.

With its advanced PE/Cyanine7 conjugation, this antibody offers unparalleled fluorescence intensity, enabling precise and reliable identification of CD274/PD-L1 expression on human cells. Its exceptional binding affinity ensures accurate and robust results, making it an indispensable tool for researchers and clinicians alike.

The PE/Cyanine7 Anti-Human CD274/PD-L1 Antibody [29E.2A3] exhibits exceptional performance across a wide range of applications, including flow cytometry, immunohistochemistry, and immunofluorescence. Its versatility allows for comprehensive analysis of CD274/PD-L1 expression in various biological samples, facilitating in-depth investigations into immune responses and disease progression.

Furthermore, this antibody's exceptional specificity guarantees minimal cross-reactivity, ensuring reliable and precise results. Its high sensitivity enables the detection of even low levels of CD274/PD-L1 expression, providing valuable insights into immune evasion mechanisms and potential therapeutic targets.

Our PE/Cyanine7 Anti-Human CD274/PD-L1 Antibody [29E.2A3] is manufactured under stringent quality control measures, ensuring consistent and reproducible performance. Each batch undergoes rigorous testing to meet the highest standards of excellence, guaranteeing optimal performance and reliability.

In summary, the PE/Cyanine7 Anti-Human CD274/PD-L1 Antibody [29E.2A3] represents a breakthrough in immunological research, offering exceptional specificity, sensitivity, and versatility. With its advanced features and reliable performance, this antibody is an indispensable tool for scientists and clinicians aiming to unravel the complexities of immune regulation and develop innovative therapeutic strategies.